Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia

Detalles Bibliográficos
Autores principales: Fodstad, Philip, Dheyauldeen, Sinan, Rinde, Marit, Bachmann-Harildstad, Gregor
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070877/
https://www.ncbi.nlm.nih.gov/pubmed/20824275
http://dx.doi.org/10.1007/s00277-010-1063-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070877/
https://www.ncbi.nlm.nih.gov/pubmed/20824275
http://dx.doi.org/10.1007/s00277-010-1063-5

Ejemplares similares